| Pt For All Pc | |
|
9952 66th Rd Lbby C, Rego Park, NY 11374-4461 | |
| (718) 263-6288 | |
| (646) 395-1895 |
| Full Name | Pt For All Pc |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 9952 66th Rd Lbby C, Rego Park, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184941395 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 029811-1 (New York) | Primary |
| Provider Name | David D Kalen |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1477665982 PECOS PAC ID: 8224127204 Enrollment ID: I20071128000392 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Provider Name | Fiana Yaroslavskaya |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1376721472 PECOS PAC ID: 9638245020 Enrollment ID: I20080909000418 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Provider Name | Zinaida Veytsman |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1568785905 PECOS PAC ID: 1557493087 Enrollment ID: I20100720000457 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Provider Name | Gehan Abdelmalak |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1558791426 PECOS PAC ID: 9436572070 Enrollment ID: I20200715000117 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Provider Name | Stella Yagudayeva |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1033714183 PECOS PAC ID: 1850707852 Enrollment ID: I20210316002021 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Provider Name | Bella Borukhova |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720788748 PECOS PAC ID: 1951767649 Enrollment ID: I20230523001307 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pt For All Pc 9952 66th Rd Apt 9z, Rego Park, NY 11374-4429 Ph: (718) 263-6388 | Pt For All Pc 9952 66th Rd Lbby C, Rego Park, NY 11374-4461 Ph: (718) 263-6288 |
News Archive
Florida Hospital, Sanford-Burnham Medical Research Institute (Sanford-Burnham), and Takeda Pharmaceutical Company Limited (Takeda)(TSE: 4502), announced today that they have signed a research agreement to form a collaboration to discover and evaluate new therapeutic approaches to obesity, a growing worldwide health problem. The partnership aligns complementary strengths in biomedical research, clinical research and drug development to identify and validate obesity- related biomarkers and new peripheral molecular targets of mutual interest.
The AP/Philadelphia Inquirer on Thursday examined how outpatient surgery centers are "poised to outnumber general hospitals, if they do not already."
Rich Pharmaceuticals, Inc. is pleased to announce that the Company has received approval from the U.S. Food and Drug Administration to commence its Phase 1/2 clinical for the treatment of Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) patients.
Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs' Endothelial Corneal Dystrophy.
› Verified 2 days ago
Mr. Nino Pompeyo Rocco Altamirano Borja, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6241 Woodhaven Blvd, Rego Park, NY 11374 Phone: 929-607-3271 Fax: 929-607-3267 | |
Nypt Rehab Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6607 Alderton St, Rego Park, NY 11374 Phone: 718-275-7790 Fax: 718-358-3837 | |
Lichieh Pao, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6541 Wetherole St, Rego Park, NY 11374 Phone: 917-862-7787 | |
Mikaela Adriano Lagman, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 98120 Queens Blvd Ste 1lm, Rego Park, NY 11374 Phone: 718-897-3333 Fax: 718-997-0342 | |
Ralph Arden Paul Fuster Murillo, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6288 Austin St, Rego Park, NY 11374 Phone: 718-314-5849 | |
Rhyan Fermin Florendo, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 9748 64th Ave Fl 2, Rego Park, NY 11374 Phone: 510-367-7730 | |
Stephanie Patricia Siry, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6601 Burns St Apt 6y, Rego Park, NY 11374 Phone: 646-418-9513 |